Accelerometers' Validity in Counting Number of Steps in the Elderly Subjects Before Discharge From Rehabilitation Units
VAPODAGE
2 other identifiers
interventional
120
1 country
1
Brief Summary
Accelerometers enhance physical activity. Nevertheless, their validity (ability to accurately count steps) is not known in an elderly frail population ready for discharge from a rehabilitation unit. The objective was to assess accelerometers' validity for counting steps (10 meters), in comparison with the gold standard: steps counted by 2 physicians blind to accelerometers data, over a filmed 10-meter walk (minimal capacity to walk inside their own living place). The second objective was to evaluate the best position of the accelerometer: wrist, ankle, hip.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 9, 2018
CompletedFirst Posted
Study publicly available on registry
October 11, 2018
CompletedStudy Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 29, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 29, 2019
CompletedNovember 19, 2019
April 1, 2019
6 months
October 9, 2018
November 18, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Matching between number of steps measured by the accelerometers and the number of steps counted by the physicians visioning the film.
A step is counted when a foot touches the ground
3 days maximum (The 10-meter walk test is conducted within 3 days of signing the consent.)
Secondary Outcomes (3)
Matching between number of steps measured by the accelerometers worn on the ankle and the number of steps counted by the physicians visioning the film.
3 days maximum (The 10-meter walk test is conducted within 3 days of signing the consent.)
Matching between number of steps measured by the accelerometers worn on the wrist and the number of steps counted by the physicians visioning the film.
3 days maximum (The 10-meter walk test is conducted within 3 days of signing the consent.)
Best matching between the number of steps evaluated by the accelerometers and the the number of steps counted by the physicians visioning the film according to the accelerometers positions (hip, ankle, wrist).
3 days maximum (The 10-meter walk test is conducted within 3 days of signing the consent.)
Study Arms (1)
Interventional
EXPERIMENTALSubjects aged \>70 years, hospitalized in the rehabilitation geriatric ward in the Paul Brousse hospital, France, able to walk 10 meters, ready to be discharged, and a Mini mental state examination ≥ 20/30
Interventions
Accelerometers are positioned at the wrinkle, the hip, and the ankle. The subject stands and walks 10 meters, followed up by a physiotherapist in the physiotherapy area. The accelerometers are triggered by a smartphone. The protocol is filmed (without the face), and 2 physicians will watch the film and count the steps blind to the results of the accelerometers (and blind to each-other steps counts)
Eligibility Criteria
You may qualify if:
- Age\> 70 years
- Patients able to walk 10 meters,
- Maximum functional recovery obtained according to the physiotherapist judgment and ready for discharge,
- Patients able to understand the instructions and to freely consent (Mini mental state examination ≥ 20/30 and score at the consent scale: UBACC≥ 12/20)
- Written consent
- Unprotected adult
- Covered by health insurance
- Impossibility to walk the required distance (severe dyspnea, post fall syndrome, blindness, ..)
- Patients participating in another interventional research.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hopital Bicêtre - Geriatric Department
Le Kremlin-Bicêtre, 94270, France
Study Officials
- PRINCIPAL INVESTIGATOR
Emmanuelle DURON, Md, PhD
APHP,Paul Brousse Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 9, 2018
First Posted
October 11, 2018
Study Start
March 1, 2019
Primary Completion
August 29, 2019
Study Completion
August 29, 2019
Last Updated
November 19, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share